Dominant-negative activator protein 1 (TAM67) targets cyclooxygenase-2 and osteopontin under conditions in which it specifically inhibits tumorigenesis.
about
Suppressor role of activating transcription factor 2 (ATF2) in skin cancerA selective small-molecule nuclear factor-kappaB inhibitor from a high-throughput cell-based assay for "activator protein-1 hits".c-Jun regulates phosphoinositide-dependent kinase 1 transcription: implication for Akt and protein kinase C activities and melanoma tumorigenesisElevated phosphate activates N-ras and promotes cell transformation and skin tumorigenesis.STAT2 contributes to promotion of colorectal and skin carcinogenesis.Signal transduction molecules as targets for cancer prevention.Emerging roles of ATF2 and the dynamic AP1 network in cancer.A dominant-negative c-jun mutant inhibits lung carcinogenesis in mice.Tumor necrosis factor-alpha augments matrix metalloproteinase-9 production in skeletal muscle cells through the activation of transforming growth factor-beta-activated kinase 1 (TAK1)-dependent signaling pathwayProtein kinases and transcription factors activation in response to UV-radiation of skin: implications for carcinogenesis.Targeting of Noncanonical Wnt5a Signaling by AP-1 Blocker Dominant-Negative Jun When It Inhibits Skin Carcinogenesis.LOXL4 is induced by transforming growth factor β1 through Smad and JunB/Fra2 and contributes to vascular matrix remodeling.Sulfiredoxin is an AP-1 target gene that is required for transformation and shows elevated expression in human skin malignancies.A review of transcriptomics in cutaneous chemical exposure.Growth factor signaling pathways as targets for prevention of epithelial carcinogenesis.KITENIN increases invasion and migration of mouse squamous cancer cells and promotes pulmonary metastasis in a mouse squamous tumor model.NF-kappaB activation in renal tubular epithelial cells by oxalate stimulation.AP1 transcription factors in epidermal differentiation and skin cancerAP1 factor inactivation in the suprabasal epidermis causes increased epidermal hyperproliferation and hyperkeratosis but reduced carcinogen-dependent tumor formationPharmacological inhibition of the transcription factor PU.1 in leukemia.The effects of dissociated glucocorticoids RU24858 and RU24782 on TPA-induced skin tumor promotion biomarkers in SENCAR mice.The role of AP-1 in self-sufficient proliferation and migration of cancer cells and its potential impact on an autocrine/paracrine loop
P2860
Q24652406-886DFD4F-6B91-472A-BB21-7CDD0343398AQ33414478-898C7EF1-5D44-429A-881B-84B7AF29565BQ33569860-63754787-8F69-41E7-83F1-7B15B9691C14Q33708051-32D12EAF-0278-45A5-8EFE-F1D7DDD31CEEQ33776485-E5BD5DD8-4F9F-4233-8B89-30C0A9A6CCD7Q33828052-DB0EA4C6-0544-40EC-8411-60167A36F6E8Q33866973-8165AEB1-9F43-4F63-B0CE-135B7C14B0FCQ34103743-ACAB5610-F857-45BB-A0A1-63DB2236D768Q34132341-602C00E1-68EC-4203-9FFB-1636C30268A5Q35719245-E0B2BC8F-D6D4-43DB-B979-1AE3C6C8B437Q36153315-763891DB-2CC5-4903-A484-88665BDB1000Q36978251-989FCFB8-BFD5-4BE5-BC49-4BD507E2E46AQ37018998-A9B06143-3A5D-4A2D-9EFF-246509C895F7Q37627265-09981C84-63B2-40F7-BA47-6306154F6BA2Q37774602-200770C4-EF18-42EC-B6BB-CF3183D8BF5CQ39891385-329C08B6-9B28-4BD5-84EF-79F483BDC44CQ39948151-A5AE60DD-7797-4D89-82FD-3A6BA9BB2A58Q41878046-DE22FB3B-AC50-48AA-9F93-3FAA3FB5F6A8Q42201057-760CD017-FB12-4E75-9A45-7635CEECC569Q46873766-27E18330-88AC-4007-A150-05FFF3B65F99Q48008122-D381589D-6371-45A6-837C-00C634281776Q57821073-C18731FD-9E43-4137-8E4D-B03E9E26683F
P2860
Dominant-negative activator protein 1 (TAM67) targets cyclooxygenase-2 and osteopontin under conditions in which it specifically inhibits tumorigenesis.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Dominant-negative activator pr ...... ically inhibits tumorigenesis.
@en
Dominant-negative activator protein 1
@nl
type
label
Dominant-negative activator pr ...... ically inhibits tumorigenesis.
@en
Dominant-negative activator protein 1
@nl
prefLabel
Dominant-negative activator pr ...... ically inhibits tumorigenesis.
@en
Dominant-negative activator protein 1
@nl
P2093
P1433
P1476
Dominant-negative activator pr ...... ically inhibits tumorigenesis.
@en
P2093
Alysia M Birkholz
Alyson R Baker
Christine M Perella
Connie P Matthews
George R Beck
Matthew R Young
Nancy H Colburn
P304
P356
10.1158/0008-5472.CAN-06-0522
P407
P577
2007-03-01T00:00:00Z